Although HGF-MET signaling induced SPRY2 expression in leiomyosarcoma35, we found that SPRY2 levels were higher in ERMS cells that have low MET expression, compared to ARMS cells, suggesting additional mechanisms regulate SPRY2. The gene discussed is SPRY2; the disease is alveolar rhabdomyosarcoma.